Content
04/04/2025
San Diego, CA USA
RayThera
completed $110 million Series A Round funding. Investors include
OrbiMed Advisors (lead), Foresite Capital (lead), TTM Capital.
About
RayThera, Inc. is a small molecule drug discovery company focused on building an immunology pipeline.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
